Private Advisor Group LLC increased its stake in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 9,220.4% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 131,325 shares of the medical equipment provider’s stock after purchasing an additional 129,916 shares during the period. Private Advisor Group LLC owned approximately 0.19% of Align Technology worth $17,402,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ALGN. BlackRock Inc. bought a new stake in Align Technology in the 2nd quarter worth approximately $745,370,000. Assenagon Asset Management S.A. raised its stake in Align Technology by 638.7% during the 3rd quarter. Assenagon Asset Management S.A. now owns 4,662,437 shares of the medical equipment provider’s stock valued at $629,469,000 after buying an additional 4,031,284 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its stake in Align Technology by 3,162.7% during the 3rd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,097,745 shares of the medical equipment provider’s stock valued at $278,342,000 after buying an additional 2,033,451 shares during the last quarter. Vontobel Holding Ltd. lifted its holdings in shares of Align Technology by 69,628.9% during the 3rd quarter. Vontobel Holding Ltd. now owns 1,385,513 shares of the medical equipment provider’s stock valued at $183,335,000 after buying an additional 1,383,526 shares during the period. Finally, HighTower Advisors LLC lifted its holdings in shares of Align Technology by 17,371.1% during the 3rd quarter. HighTower Advisors LLC now owns 1,348,416 shares of the medical equipment provider’s stock valued at $178,523,000 after buying an additional 1,340,698 shares during the period. Institutional investors own 88.43% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on the company. Zacks Research upgraded Align Technology from a “strong sell” rating to a “hold” rating in a research note on Friday, November 13th. Needham & Company LLC reiterated a “hold” rating on shares of Align Technology in a research report on Thursday, October 29th. Stifel Nicolaus lowered their target price on Align Technology from $210.00 to $175.00 and set a “buy” rating on the stock in a report on Friday, October 9th. Piper Sandler dropped their target price on Align Technology from $235.00 to $205.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 21st. Finally, Morgan Stanley dropped their target price on Align Technology from $188.00 to $175.00 and set an “equal weight” rating on the stock in a research report on Thursday, October 29th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, Align Technology currently has a consensus rating of “Moderate Buy” and a consensus price target of $193.08.
Get Our Latest Stock Report on Align Technology
Align Technology Trading Down 2.8%
ALGN opened at $155.13 on Friday. Align Technology, Inc. has a 1-year low of $132.63 and a 1-year high of $200.43. The company has a market capitalization of $10.94 billion, a PE ratio of 22.58, a PEG ratio of 2.15 and a beta of 1.74. The firm’s 50 day simple moving average is $152.50 and its two-hundred day simple moving average is $168.54.
Align Technology (NASDAQ:ALGN – Get Free Report) last issued its quarterly earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.77 by $0.03. Align Technology had a net margin of 11.83% and a return on equity of 15.96%. The business had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1 billion. During the same quarter last year, the company posted $2.61 EPS. The company’s revenue was up 1.9% compared to the same quarter last year. Equities analysts forecast that Align Technology, Inc. will post 9.21 earnings per share for the current fiscal year.
Align Technology Profile
Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.
Recommended Stories
- Five stocks we like better than Align Technology
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.
